Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans
Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipide...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Davidson, Michael H. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: No title available - 230(2013), 2, Seite 322-329 |
|---|---|
| Übergeordnetes Werk: |
volume:230 ; year:2013 ; number:2 ; pages:322-329 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.atherosclerosis.2013.08.006 |
|---|
| Katalog-ID: |
ELV027627179 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV027627179 | ||
| 003 | DE-627 | ||
| 005 | 20230623190826.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.atherosclerosis.2013.08.006 |2 doi | |
| 028 | 5 | 2 | |a /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2013021000021.pica |
| 035 | |a (DE-627)ELV027627179 | ||
| 035 | |a (ELSEVIER)S0021-9150(13)00481-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Davidson, Michael H. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans |
| 264 | 1 | |c 2013 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. | ||
| 650 | 7 | |a Fecal sterols |2 Elsevier | |
| 650 | 7 | |a Ezetimibe |2 Elsevier | |
| 650 | 7 | |a Reverse cholesterol transport |2 Elsevier | |
| 650 | 7 | |a Cholesterol absorption |2 Elsevier | |
| 650 | 7 | |a Cholesterol efflux |2 Elsevier | |
| 700 | 1 | |a Voogt, Jason |4 oth | |
| 700 | 1 | |a Luchoomun, Jayraz |4 oth | |
| 700 | 1 | |a Decaris, Julie |4 oth | |
| 700 | 1 | |a Killion, Salena |4 oth | |
| 700 | 1 | |a Boban, Drina |4 oth | |
| 700 | 1 | |a Glass, Alexander |4 oth | |
| 700 | 1 | |a Mohammad, Hussein |4 oth | |
| 700 | 1 | |a Lu, Yun |4 oth | |
| 700 | 1 | |a Villegas, Deona |4 oth | |
| 700 | 1 | |a Neese, Richard |4 oth | |
| 700 | 1 | |a Hellerstein, Marc |4 oth | |
| 700 | 1 | |a Neff, David |4 oth | |
| 700 | 1 | |a Musliner, Thomas |4 oth | |
| 700 | 1 | |a Tomassini, Joanne E. |4 oth | |
| 700 | 1 | |a Turner, Scott |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t No title available |g 230(2013), 2, Seite 322-329 |w (DE-627)ELV012595616 |w (DE-600)1-9150 |7 nnns |
| 773 | 1 | 8 | |g volume:230 |g year:2013 |g number:2 |g pages:322-329 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.atherosclerosis.2013.08.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_105 | ||
| 951 | |a AR | ||
| 952 | |d 230 |j 2013 |e 2 |h 322-329 |g 8 | ||
| author_variant |
m h d mh mhd |
|---|---|
| matchkey_str |
davidsonmichaelhvoogtjasonluchoomunjayra:2013----:niiinfnetnlhlseoasrtowteeiienraecmoetorvre |
| hierarchy_sort_str |
2013 |
| publishDate |
2013 |
| allfields |
10.1016/j.atherosclerosis.2013.08.006 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2013021000021.pica (DE-627)ELV027627179 (ELSEVIER)S0021-9150(13)00481-4 DE-627 ger DE-627 rakwb eng Davidson, Michael H. verfasserin aut Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans 2013 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux Elsevier Voogt, Jason oth Luchoomun, Jayraz oth Decaris, Julie oth Killion, Salena oth Boban, Drina oth Glass, Alexander oth Mohammad, Hussein oth Lu, Yun oth Villegas, Deona oth Neese, Richard oth Hellerstein, Marc oth Neff, David oth Musliner, Thomas oth Tomassini, Joanne E. oth Turner, Scott oth Enthalten in No title available 230(2013), 2, Seite 322-329 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:230 year:2013 number:2 pages:322-329 extent:8 https://doi.org/10.1016/j.atherosclerosis.2013.08.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 230 2013 2 322-329 8 |
| spelling |
10.1016/j.atherosclerosis.2013.08.006 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2013021000021.pica (DE-627)ELV027627179 (ELSEVIER)S0021-9150(13)00481-4 DE-627 ger DE-627 rakwb eng Davidson, Michael H. verfasserin aut Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans 2013 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux Elsevier Voogt, Jason oth Luchoomun, Jayraz oth Decaris, Julie oth Killion, Salena oth Boban, Drina oth Glass, Alexander oth Mohammad, Hussein oth Lu, Yun oth Villegas, Deona oth Neese, Richard oth Hellerstein, Marc oth Neff, David oth Musliner, Thomas oth Tomassini, Joanne E. oth Turner, Scott oth Enthalten in No title available 230(2013), 2, Seite 322-329 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:230 year:2013 number:2 pages:322-329 extent:8 https://doi.org/10.1016/j.atherosclerosis.2013.08.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 230 2013 2 322-329 8 |
| allfields_unstemmed |
10.1016/j.atherosclerosis.2013.08.006 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2013021000021.pica (DE-627)ELV027627179 (ELSEVIER)S0021-9150(13)00481-4 DE-627 ger DE-627 rakwb eng Davidson, Michael H. verfasserin aut Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans 2013 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux Elsevier Voogt, Jason oth Luchoomun, Jayraz oth Decaris, Julie oth Killion, Salena oth Boban, Drina oth Glass, Alexander oth Mohammad, Hussein oth Lu, Yun oth Villegas, Deona oth Neese, Richard oth Hellerstein, Marc oth Neff, David oth Musliner, Thomas oth Tomassini, Joanne E. oth Turner, Scott oth Enthalten in No title available 230(2013), 2, Seite 322-329 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:230 year:2013 number:2 pages:322-329 extent:8 https://doi.org/10.1016/j.atherosclerosis.2013.08.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 230 2013 2 322-329 8 |
| allfieldsGer |
10.1016/j.atherosclerosis.2013.08.006 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2013021000021.pica (DE-627)ELV027627179 (ELSEVIER)S0021-9150(13)00481-4 DE-627 ger DE-627 rakwb eng Davidson, Michael H. verfasserin aut Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans 2013 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux Elsevier Voogt, Jason oth Luchoomun, Jayraz oth Decaris, Julie oth Killion, Salena oth Boban, Drina oth Glass, Alexander oth Mohammad, Hussein oth Lu, Yun oth Villegas, Deona oth Neese, Richard oth Hellerstein, Marc oth Neff, David oth Musliner, Thomas oth Tomassini, Joanne E. oth Turner, Scott oth Enthalten in No title available 230(2013), 2, Seite 322-329 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:230 year:2013 number:2 pages:322-329 extent:8 https://doi.org/10.1016/j.atherosclerosis.2013.08.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 230 2013 2 322-329 8 |
| allfieldsSound |
10.1016/j.atherosclerosis.2013.08.006 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2013021000021.pica (DE-627)ELV027627179 (ELSEVIER)S0021-9150(13)00481-4 DE-627 ger DE-627 rakwb eng Davidson, Michael H. verfasserin aut Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans 2013 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux Elsevier Voogt, Jason oth Luchoomun, Jayraz oth Decaris, Julie oth Killion, Salena oth Boban, Drina oth Glass, Alexander oth Mohammad, Hussein oth Lu, Yun oth Villegas, Deona oth Neese, Richard oth Hellerstein, Marc oth Neff, David oth Musliner, Thomas oth Tomassini, Joanne E. oth Turner, Scott oth Enthalten in No title available 230(2013), 2, Seite 322-329 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:230 year:2013 number:2 pages:322-329 extent:8 https://doi.org/10.1016/j.atherosclerosis.2013.08.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 230 2013 2 322-329 8 |
| language |
English |
| source |
Enthalten in No title available 230(2013), 2, Seite 322-329 volume:230 year:2013 number:2 pages:322-329 extent:8 |
| sourceStr |
Enthalten in No title available 230(2013), 2, Seite 322-329 volume:230 year:2013 number:2 pages:322-329 extent:8 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Fecal sterols Ezetimibe Reverse cholesterol transport Cholesterol absorption Cholesterol efflux |
| isfreeaccess_bool |
false |
| container_title |
No title available |
| authorswithroles_txt_mv |
Davidson, Michael H. @@aut@@ Voogt, Jason @@oth@@ Luchoomun, Jayraz @@oth@@ Decaris, Julie @@oth@@ Killion, Salena @@oth@@ Boban, Drina @@oth@@ Glass, Alexander @@oth@@ Mohammad, Hussein @@oth@@ Lu, Yun @@oth@@ Villegas, Deona @@oth@@ Neese, Richard @@oth@@ Hellerstein, Marc @@oth@@ Neff, David @@oth@@ Musliner, Thomas @@oth@@ Tomassini, Joanne E. @@oth@@ Turner, Scott @@oth@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
ELV012595616 |
| id |
ELV027627179 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027627179</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623190826.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.atherosclerosis.2013.08.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2013021000021.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027627179</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0021-9150(13)00481-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Davidson, Michael H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fecal sterols</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ezetimibe</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Reverse cholesterol transport</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cholesterol absorption</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cholesterol efflux</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Voogt, Jason</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Luchoomun, Jayraz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Decaris, Julie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Killion, Salena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boban, Drina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Glass, Alexander</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mohammad, Hussein</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lu, Yun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Villegas, Deona</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neese, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hellerstein, Marc</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neff, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Musliner, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomassini, Joanne E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turner, Scott</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">230(2013), 2, Seite 322-329</subfield><subfield code="w">(DE-627)ELV012595616</subfield><subfield code="w">(DE-600)1-9150</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:230</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:322-329</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.atherosclerosis.2013.08.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">230</subfield><subfield code="j">2013</subfield><subfield code="e">2</subfield><subfield code="h">322-329</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Davidson, Michael H. |
| spellingShingle |
Davidson, Michael H. Elsevier Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans |
| authorStr |
Davidson, Michael H. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012595616 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux Elsevier |
| topic |
Elsevier Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux |
| topic_unstemmed |
Elsevier Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux |
| topic_browse |
Elsevier Fecal sterols Elsevier Ezetimibe Elsevier Reverse cholesterol transport Elsevier Cholesterol absorption Elsevier Cholesterol efflux |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j v jv j l jl j d jd s k sk d b db a g ag h m hm y l yl d v dv r n rn m h mh d n dn t m tm j e t je jet s t st |
| hierarchy_parent_title |
No title available |
| hierarchy_parent_id |
ELV012595616 |
| hierarchy_top_title |
No title available |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV012595616 (DE-600)1-9150 |
| title |
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans |
| ctrlnum |
(DE-627)ELV027627179 (ELSEVIER)S0021-9150(13)00481-4 |
| title_full |
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans |
| author_sort |
Davidson, Michael H. |
| journal |
No title available |
| journalStr |
No title available |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
322 |
| author_browse |
Davidson, Michael H. |
| container_volume |
230 |
| physical |
8 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Davidson, Michael H. |
| doi_str_mv |
10.1016/j.atherosclerosis.2013.08.006 |
| title_sort |
inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans |
| title_auth |
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans |
| abstract |
Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. |
| abstractGer |
Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. |
| abstract_unstemmed |
Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 |
| container_issue |
2 |
| title_short |
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans |
| url |
https://doi.org/10.1016/j.atherosclerosis.2013.08.006 |
| remote_bool |
true |
| author2 |
Voogt, Jason Luchoomun, Jayraz Decaris, Julie Killion, Salena Boban, Drina Glass, Alexander Mohammad, Hussein Lu, Yun Villegas, Deona Neese, Richard Hellerstein, Marc Neff, David Musliner, Thomas Tomassini, Joanne E. Turner, Scott |
| author2Str |
Voogt, Jason Luchoomun, Jayraz Decaris, Julie Killion, Salena Boban, Drina Glass, Alexander Mohammad, Hussein Lu, Yun Villegas, Deona Neese, Richard Hellerstein, Marc Neff, David Musliner, Thomas Tomassini, Joanne E. Turner, Scott |
| ppnlink |
ELV012595616 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.atherosclerosis.2013.08.006 |
| up_date |
2024-07-06T16:44:00.554Z |
| _version_ |
1803848767824199680 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027627179</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623190826.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.atherosclerosis.2013.08.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2013021000021.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027627179</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0021-9150(13)00481-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Davidson, Michael H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Reverse cholesterol transport (RCT) can be defined as a pathway of flux of cholesterol from peripheral tissues to the liver for potential excretion into feces. This prospective, placebo-controlled, double-blind crossover study assessed the effect of ezetimibe on several RCT parameters in hyperlipidemic patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fecal sterols</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ezetimibe</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Reverse cholesterol transport</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cholesterol absorption</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cholesterol efflux</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Voogt, Jason</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Luchoomun, Jayraz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Decaris, Julie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Killion, Salena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boban, Drina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Glass, Alexander</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mohammad, Hussein</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lu, Yun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Villegas, Deona</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neese, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hellerstein, Marc</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neff, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Musliner, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomassini, Joanne E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turner, Scott</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">230(2013), 2, Seite 322-329</subfield><subfield code="w">(DE-627)ELV012595616</subfield><subfield code="w">(DE-600)1-9150</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:230</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:322-329</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.atherosclerosis.2013.08.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">230</subfield><subfield code="j">2013</subfield><subfield code="e">2</subfield><subfield code="h">322-329</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.4021635 |